nCino (NCNO) files Rule 144 to sell 379,083 shares on Nasdaq
Rhea-AI Filing Summary
Form 144 Notice: This filing is a Rule 144 notice of a proposed sale of 379,083 shares of common stock of the issuer through Merrill Lynch Pierce Fenner and Smith on 09/08/2025 on Nasdaq. The filing shows an aggregate market value of $11,524,123.20 and reports 115,814,720 shares outstanding.
The securities were acquired on 06/15/2020 in a private placement from the issuer, paid in cash. The filer reports no securities sold in the past three months and includes the required representation that the person does not possess undisclosed material adverse information regarding the issuer.
Positive
- Full procedural disclosure of proposed sale including broker, share count, market value, and sale date
- Securities were acquired in a private placement with payment in cash, with acquisition date documented (06/15/2020)
- No securities sold in the past three months reported, indicating this filing is not part of frequent recent disposals
Negative
- Material block size: proposed sale represents a significant single transaction with an aggregate market value of $11,524,123.20
- Limited issuer detail: filing provides no supplementary information about the reason for the sale or the identity of the selling person
Insights
TL;DR: Routine Rule 144 notice proposing sale of 379,083 shares worth $11.5M; transaction appears procedural rather than disclosure of new adverse facts.
The filing documents a planned block sale executed through a major broker with explicit details on share count, market value, acquisition date and method. The absence of reported sales in the prior three months and the representation regarding undisclosed material adverse information are standard elements for compliance. From a liquidity perspective, the filing quantifies the supply proposed to enter the market but provides no information about purchaser identity or any change in issuer fundamentals.
TL;DR: Compliance-focused disclosure: the filer meets Rule 144 reporting requirements and affirms no undisclosed material adverse information.
The form includes the required signatures and statements, the broker designation, and the detailed origin of the shares (private placement on 06/15/2020 from the issuer). These elements satisfy procedural governance expectations for insider or affiliated-holder sales under Rule 144. The filing does not indicate any governance actions, executive changes, or regulatory issues beyond the proposed sale itself.